Skip to main content
S&P 5007,801.77-0.22%DOW51,179.87-0.66%NASDAQ27,538.69-0.22%BTC$83,159.00-2.82%ETH$2,565.93-4.83%GOLD$4,136.70-0.10%OIL$88.94+0.75%
Smart Investors Daily
SID Premium
Integra LifeSciences Holdings Corporation logo

NASDAQ · IART

Integra LifeSciences Holdings Corporation

Healthcare · Medical - Devices

$13.32

Down-$0.32 (-2.40%)

Updated Oct 7, 2026, 9:44 PM

SID Score

4.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.1B
P/E ratio
-2.18
Dividend yield
0.00%
52-week range
$8.70 – $20.49
Volume
1.37M
Avg. volume
1.05M

Price performance · IART

IART price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

IART closed at $13.32 after 21 trading sessions, down 18.08% for the selected period.

Last close
$13.32
Period change
-18.08%
Period low
$12.68
Period high
$16.64
Daily close
View OHLC price history
IART OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$13.46$13.51$12.88$13.321.37M
Oct 5, 2026$12.65$13.485$12.35$13.291.86M
Oct 2, 2026$13.31$14.00$12.63$12.682.7M
Oct 1, 2026$16.21$16.45$15.88$16.09652.94K
Sep 30, 2026$16.67$16.67$16.14$16.28768.91K
Sep 29, 2026$16.27$16.765$15.80$16.641.01M
Sep 28, 2026$16.04$16.27$15.86$16.27479.05K
Sep 25, 2026$15.88$16.21$15.74$16.12539.03K
Sep 24, 2026$15.67$15.91$15.49$15.88759.53K
Sep 23, 2026$15.88$16.26$15.38$15.53573.08K
Sep 22, 2026$15.90$16.285$15.69$16.02770.45K
Sep 21, 2026$15.06$15.65$14.91$15.591.06M
Sep 18, 2026$14.98$15.24$14.875$15.222.17M
Sep 17, 2026$16.30$16.375$15.07$15.101.05M
Sep 16, 2026$15.81$16.22$15.65$16.061.62M
Sep 15, 2026$15.69$16.035$15.20$15.691.08M
Sep 14, 2026$15.36$15.80$15.36$15.711.14M
Sep 11, 2026$16.06$16.22$15.33$15.50792.03K
Sep 10, 2026$15.93$16.035$15.3878$15.541.36M
Sep 9, 2026$16.10$16.46$15.99$16.25578.4K
Sep 8, 2026$16.48$16.5498$15.985$16.26621.8K

Latest IART news

The latest Smart Investors Daily articles mentioning IART.

Stock researchCompany · Overview

IART research

Overview

Company profile and research snapshot.

Company profile

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$15.00
Implied upside
—
Analysts
—
IART recent ratings
DateFirmRatingTarget
Oct 5, 2026BMO CapitalMarket Perform—
Oct 5, 2026CitigroupNeutral—
Jul 30, 2026Wells FargoEqual-Weight—
Jul 28, 2026UBSNeutral—
Jul 16, 2026Truist SecuritiesHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 6, 2026

Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026

PRINCETON, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2026 financial results on Wednesday, October 21, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those pla

Yahoo · Oct 2, 2026

Why Integra LifeSciences (IART) Stock Is Nosediving

Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 15.3% in the morning session after the company released preliminary third-quarter 2026 results and reduced its full-year revenue and adjusted EPS guidance due to operational disruption caused by a July 2026 flood at its Cincinnati facility.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By